» Articles » PMID: 8604187

Heroin-related Deaths in New South Wales, 1992: Toxicological Findings and Circumstances

Overview
Journal Med J Aust
Specialty General Medicine
Date 1996 Feb 19
PMID 8604187
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the circumstances of death and toxicological findings in all heroin-related deaths in New South Wales in 1992.

Design: Coronial files of all cases of heroin-related deaths were reviewed. A standardised form was used to collect information on sociodemographics, history of drug use, circumstances of death, and results of toxicological analysis for each case.

Results: 152 heroin-related deaths were identified. Subjects had a mean age of 29.7 years, 82% were male, and 98% were not enrolled in a methadone treatment program at the time of their deaths. Deaths occurred in the home environment in 68% of cases and in the company of at least one other person in 58%. There was intervention before the subject's death in only 21% of cases. Two or more drug classes were detected in 71% of subjects; alcohol was detected in 45%, with a mean blood alcohol concentration of 0.14 g/100mL.

Conclusions: Fatal heroin overdose is potentially preventable. Educating users about the risks of co-administering alcohol and other depressant drugs with heroin, the comparative safety of injecting heroin in the company of others and the need to call for intervention sooner may reduce the frequency of heroin-related deaths.

Citing Articles

Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.

Coffin P, Maya S, Kahn J Drug Alcohol Depend. 2022; 236:109478.

PMID: 35588609 PMC: 9235402. DOI: 10.1016/j.drugalcdep.2022.109478.


The Polysubstance Overdose-Death Crisis.

Peppin J, Raffa R, Schatman M J Pain Res. 2020; 13:3405-3408.

PMID: 33364823 PMC: 7751289. DOI: 10.2147/JPR.S295715.


Impact of the take ACTION Train-the-Trainer model of opioid overdose education with naloxone distribution- who benefits?.

Dahlem C, Scalera M, Chen B, McCabe S, Boyd C Subst Abus. 2019; 41(4):485-492.

PMID: 31638875 PMC: 11608094. DOI: 10.1080/08897077.2019.1671946.


Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.

Strang J, McDonald R, Campbell G, Degenhardt L, Nielsen S, Ritter A Drugs. 2019; 79(13):1395-1418.

PMID: 31352603 PMC: 6728289. DOI: 10.1007/s40265-019-01154-5.


Concurrent Use of Benzodiazepine by Heroin Users-What Are the Prevalence and the Risks Associated with This Pattern of Use?.

Yamamoto T, Dargan P, Dines A, Yates C, Heyerdahl F, Hovda K J Med Toxicol. 2018; 15(1):4-11.

PMID: 30066312 PMC: 6314928. DOI: 10.1007/s13181-018-0674-4.